{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:10:08Z","timestamp":1782393008857,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartfailure.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.hfc.2016.12.011","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T09:33:30Z","timestamp":1488879210000},"page":"347-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["How to Develop a Cardio-Oncology Clinic"],"prefix":"10.1016","volume":"13","author":[{"given":"David","family":"Snipelisky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Mulvagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rodriguez-Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector R.","family":"Villarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2016.12.011_bib1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCRESAHA.113.300218","article-title":"Emerging paradigms in cardiomyopathies associated with cancer therapies","volume":"113","author":"Ky","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2016.12.011_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/imj.12532","article-title":"Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship","volume":"44","author":"Nolan","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.hfc.2016.12.011_bib3","first-page":"126","article-title":"Cardio-oncology: a new medical issue","volume":"2","author":"Cardinale","year":"2008","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.hfc.2016.12.011_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrcardio.2015.133","article-title":"Cardiotoxicity of anticancer treatments","volume":"12","author":"Ewer","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hfc.2016.12.011_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrcardio.2010.121","article-title":"Cardiotoxicity of anticancer treatments: what the cardiologist needs to know","volume":"7","author":"Ewer","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hfc.2016.12.011_bib6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2016.12.011_bib7","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","article-title":"Evaluation and management of patients with heart disease and cancer: cardio-oncology","volume":"89","author":"Herrmann","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hfc.2016.12.011_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tcm.2014.07.003","article-title":"An update on cardio-oncology","volume":"24","author":"Herrmann","year":"2014","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hfc.2016.12.011_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2016.2132","article-title":"Oncocardiology - past, present, and future: a review","author":"Yeh","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hfc.2016.12.011_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hfc.2016.12.011_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurjhf\/hfq213","article-title":"Cardiovascular side effects of cancer therapies: a position statement fromthe Heart Failure Association of the European Society of Cardiology","volume":"13","author":"Eschenhagen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2016.12.011_bib12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2016.12.011_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A clinicopathologic analysis of adriamycin cardiotoxicity","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.hfc.2016.12.011_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM197902083000603","article-title":"Serial assessment of doxorubicin cardiotoxicity with quantiative radionuclide angiocardiography","volume":"300","author":"Alexander","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2016.12.011_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.hfc.2011.03.001","article-title":"A\u00a0historical perspective of anthracycline cardiotoxicity","volume":"7","author":"Ewer","year":"2011","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.hfc.2016.12.011_bib16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hfc.2016.12.011_bib17","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.hfc.2016.12.011_bib18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1200\/JCO.1998.16.2.545","article-title":"Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia","volume":"16","author":"Nysom","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hfc.2016.12.011_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2016.12.011_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-016-0514-0","article-title":"Tyrosine kinase inhibitors and vascular toxicity: impetus for a classification system?","volume":"18","author":"Herrmann","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.hfc.2016.12.011_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jama.2014.15939","article-title":"The anatomy of medical research: US and international comparisons","volume":"313","author":"Moses","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2016.12.011_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pharmthera.2013.03.005","article-title":"Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity","volume":"138","author":"Ferri","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.hfc.2016.12.011_bib23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1470-2045(06)70940-8","article-title":"Multidisciplinary teams in cancer care: are they effective in the UK?","volume":"7","author":"Fleissig","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hfc.2016.12.011_bib24","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","article-title":"Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level","volume":"65","author":"Barac","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2016.12.011_bib25","first-page":"1","article-title":"Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic","volume":"2","author":"Barros-Gomes","year":"2016","journal-title":"Cardiooncology"},{"key":"10.1016\/j.hfc.2016.12.011_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijcard.2016.03.237","article-title":"Organisation & models of cardio-oncology clinics","volume":"214","author":"Gujral","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2016.12.011_bib27","first-page":"671232","article-title":"Clinical experience of patients referred to a multidisciplinary Cardiac Oncology Clinic: an observational study","volume":"2015","author":"Sulpher","year":"2015","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.hfc.2016.12.011_bib28","first-page":"391848","article-title":"An international survey of health care providers involved in the management of cancer patients exposed to cardiotoxic therapy","volume":"2015","author":"Sulpher","year":"2015","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.hfc.2016.12.011_bib29","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jacc.2015.07.033","article-title":"Burgeoning cardio-oncology programs: challenges and opportunities for early career cardiologists\/faculty directors","volume":"66","author":"Okwuosa","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2016.12.011_bib30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.echo.2013.07.005","article-title":"Expert consensus for multi-modality imaging evaluation of\u00a0cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"26","author":"Lancellotti","year":"2013","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2016.12.011_bib31","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ccd.26375","volume":"87","author":"Iliescu","year":"2016","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713616301738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713616301738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T15:51:32Z","timestamp":1535989892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713616301738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1551713616301738"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2016.12.011","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to Develop a Cardio-Oncology Clinic","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2016.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}